Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I study (Q46827347)
Jump to navigation
Jump to search
scientific article published in January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I study |
scientific article published in January 2006 |
Statements
1 reference
Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I study (English)
1 reference
Michael C Dobelbower
1 reference
Suzanne M Russo
1 reference
Kevin P Raisch
1 reference
Leisa L Seay
1 reference
Lisa K Clemons
1 reference
Susan Suter
1 reference
James Posey
1 reference
James A Bonner
1 reference
1 January 2006
1 reference
1 reference
17
1 reference
1
1 reference
95-102
1 reference
Identifiers
1 reference